Pay in 4 interest-free payments of $5.02 Learn more
Ships within 48 hours · Estimated delivery Oct 10 - Oct 15
Ziebarth J, Mainardes RM
Both in vivo and in vitro experiments have demonstrated that the GLS1 inhibitor BPTES normalized the effector function of CD4 + T cells and effectively improved the dysregulation of exocrine glands in Sjogrens syndrome (SS) ( + T cells and thus slows the progression of SS ( Table 1 )
Ongoing monitoring is essential
The Outsourcing Facilities Association filed a lawsuit against the FDA on February 24, 2025, challenging the determination that the semaglutide shortage had been resolved
Some of the companies White and colleagues investigated display customer testimonials on their websites or social media ads trumpeting how well the products work for weight management or suggesting they could be used by humans for non-research purposes
